| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase binding | UNC13B KNTC1 CCDC186 SPTBN1 NCF2 IQGAP1 DOCK5 PKN2 DENND5A MAP2K1 FMNL1 GOLGA4 PKN3 | 2.71e-06 | 360 | 147 | 13 | GO:0051020 |
| GeneOntologyMolecularFunction | small GTPase binding | UNC13B KNTC1 CCDC186 NCF2 IQGAP1 DOCK5 PKN2 DENND5A MAP2K1 FMNL1 GOLGA4 PKN3 | 4.69e-06 | 321 | 147 | 12 | GO:0031267 |
| GeneOntologyMolecularFunction | calmodulin binding | 5.30e-05 | 230 | 147 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.61e-04 | 3 | 147 | 2 | GO:0043993 | |
| GeneOntologyBiologicalProcess | organelle localization | UNC13B KNTC1 MARK1 CCDC186 TSC1 KAT2A PDPK2P MFN1 SPAG5 CEP63 HOOK3 AKAP9 NDC80 VPS33B ASPM CADPS2 MAP2K1 UNC13A | 1.85e-06 | 703 | 143 | 18 | GO:0051640 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | DPY19L3 NAA15 RASSF2 MARK1 TRPC5 BAG4 SETD4 KAT2A PDPK2P IQGAP1 CHUK EHD4 JAK1 AKAP9 VPS33B EHMT1 PKN2 EP300 PKN3 | 4.57e-05 | 976 | 143 | 19 | GO:0018193 |
| GeneOntologyBiologicalProcess | dense core granule docking | 4.77e-05 | 2 | 143 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | regulation of protein stability | NAA15 RPAP3 RASSF2 BAG4 TSC1 KAT2A CREB1 CEP63 NDC80 CCAR2 EP300 | 5.31e-05 | 368 | 143 | 11 | GO:0031647 |
| GeneOntologyBiologicalProcess | organelle fusion | 5.51e-05 | 190 | 143 | 8 | GO:0048284 | |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 6.03e-05 | 31 | 143 | 4 | GO:0016082 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | FOS TSC1 IDE PDPK2P CREB1 CHUK JAK1 FAT1 PIP4K2A GKAP1 PLCB1 NCOA1 MAP2K1 | 8.40e-05 | 530 | 143 | 13 | GO:0043434 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | UNC13B KNTC1 MARK1 CCDC186 TSC1 PDPK2P SPAG5 CEP63 HOOK3 NDC80 CADPS2 MAP2K1 UNC13A | 1.13e-04 | 546 | 143 | 13 | GO:0051656 |
| GeneOntologyBiologicalProcess | protein localization to centrosome | 1.36e-04 | 38 | 143 | 4 | GO:0071539 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 1.40e-04 | 15 | 143 | 3 | GO:1990504 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule organizing center | 1.51e-04 | 39 | 143 | 4 | GO:1905508 | |
| GeneOntologyBiologicalProcess | vesicle organization | ATP6V1C1 VPS39 RUFY1 CREB1 ATP6V1H HOOK3 VPS33B TGFBRAP1 PIP4K2A EEA1 UNC13A | 1.54e-04 | 415 | 143 | 11 | GO:0016050 |
| GeneOntologyBiologicalProcess | endosomal vesicle fusion | 1.71e-04 | 16 | 143 | 3 | GO:0034058 | |
| GeneOntologyBiologicalProcess | interstrand cross-link repair | 2.02e-04 | 42 | 143 | 4 | GO:0036297 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | UNC13B VPS39 MARK1 SPTBN1 BAG4 TSC1 KAT2A CREB1 UBLCP1 SPAG5 IQGAP1 AKAP9 IL1RAPL2 TGFBRAP1 PIP4K2A FAM9B SMCR8 TASOR EP300 UNC13A | 2.09e-04 | 1189 | 143 | 20 | GO:0044087 |
| GeneOntologyCellularComponent | HOPS complex | 1.13e-04 | 14 | 145 | 3 | GO:0030897 | |
| GeneOntologyCellularComponent | vesicle tethering complex | 1.44e-04 | 72 | 145 | 5 | GO:0099023 | |
| MousePheno | abnormal testis size | UNC13B CFAP91 RPAP3 SPTBN1 XPA IDE PDPK2P FBXO47 CHUK EHD4 CEP63 FANCD2 AXDND1 FANCB AKAP9 FANCI GKAP1 ASPM FBXO43 PLCB1 NCOA1 | 2.37e-05 | 915 | 118 | 21 | MP:0004849 |
| MousePheno | abnormal testis morphology | UNC13B CFAP91 RPAP3 FOS SPTBN1 XPA IDE PDPK2P FBXO47 CHUK EHD4 CEP63 FANCD2 AXDND1 FANCB AKAP9 FANCI GKAP1 ASPM FBXO43 PLCB1 NCOA1 PLEKHA5 | 3.05e-05 | 1081 | 118 | 23 | MP:0001146 |
| MousePheno | abnormal male genitalia morphology | UNC13B CFAP91 RPAP3 UBD ABCA13 FOS ACP3 SPTBN1 GDAP1 XPA IDE PDPK2P FBXO47 CHUK EHD4 CEP63 FANCD2 AXDND1 FANCB AKAP9 FANCI GKAP1 ASPM FBXO43 PLCB1 NCOA1 PLEKHA5 | 3.82e-05 | 1415 | 118 | 27 | MP:0009198 |
| MousePheno | abnormal male reproductive system morphology | UNC13B CFAP91 RPAP3 UBD ABCA13 FOS ACP3 SPTBN1 GDAP1 XPA IDE PDPK2P FBXO47 CHUK EHD4 CEP63 FANCD2 AXDND1 FANCB AKAP9 FANCI GKAP1 ASPM FBXO43 PLCB1 NCOA1 PLEKHA5 | 3.82e-05 | 1415 | 118 | 27 | MP:0001145 |
| MousePheno | abnormal male reproductive gland morphology | UNC13B CFAP91 RPAP3 UBD FOS ACP3 SPTBN1 XPA IDE PDPK2P FBXO47 CHUK EHD4 CEP63 FANCD2 AXDND1 FANCB AKAP9 FANCI GKAP1 ASPM FBXO43 PLCB1 NCOA1 PLEKHA5 | 6.14e-05 | 1290 | 118 | 25 | MP:0013325 |
| MousePheno | abnormal internal male genitalia morphology | UNC13B CFAP91 RPAP3 UBD FOS ACP3 SPTBN1 GDAP1 XPA IDE PDPK2P FBXO47 CHUK EHD4 CEP63 FANCD2 AXDND1 FANCB AKAP9 FANCI GKAP1 ASPM FBXO43 PLCB1 NCOA1 PLEKHA5 | 7.87e-05 | 1392 | 118 | 26 | MP:0009205 |
| MousePheno | small testis | UNC13B CFAP91 RPAP3 XPA IDE PDPK2P FBXO47 CHUK EHD4 CEP63 FANCD2 AXDND1 FANCB AKAP9 FANCI ASPM FBXO43 NCOA1 | 1.79e-04 | 823 | 118 | 18 | MP:0001147 |
| MousePheno | increased skin squamous cell carcinoma incidence | 2.11e-04 | 3 | 118 | 2 | MP:0009704 | |
| MousePheno | abnormal spermatogenesis | FOS TTC21A XPA IDE FBXO47 EHD4 CEP63 FANCD2 AXDND1 FANCB AKAP9 PSME4 FANCI GKAP1 ASPM FBXO43 HERC4 CCDC63 PMFBP1 | 2.11e-04 | 910 | 118 | 19 | MP:0001156 |
| MousePheno | abnormal male germ cell physiology | 2.22e-04 | 244 | 118 | 9 | MP:0020362 | |
| Domain | TPR_8 | 2.97e-06 | 53 | 142 | 6 | PF13181 | |
| Domain | DUF1041 | 4.26e-06 | 5 | 142 | 3 | SM01145 | |
| Domain | Munc13_1 | 1.47e-05 | 7 | 142 | 3 | IPR014770 | |
| Domain | MHD1 | 1.47e-05 | 7 | 142 | 3 | PS51258 | |
| Domain | DUF1041 | 1.47e-05 | 7 | 142 | 3 | PF06292 | |
| Domain | CAPS_dom | 1.47e-05 | 7 | 142 | 3 | IPR010439 | |
| Domain | VPS39/TGF_beta_rcpt-assoc_1 | 5.74e-05 | 2 | 142 | 2 | IPR019452 | |
| Domain | VPS39/TGF_beta_rcpt-assoc_2 | 5.74e-05 | 2 | 142 | 2 | IPR019453 | |
| Domain | Vps39_2 | 5.74e-05 | 2 | 142 | 2 | PF10367 | |
| Domain | Vps39_1 | 5.74e-05 | 2 | 142 | 2 | PF10366 | |
| Domain | Unc-13 | 1.71e-04 | 3 | 142 | 2 | IPR027080 | |
| Domain | C2_dom | 2.61e-04 | 164 | 142 | 7 | IPR000008 | |
| Domain | TPR | 4.59e-04 | 129 | 142 | 6 | SM00028 | |
| Domain | TPR_repeat | 5.40e-04 | 133 | 142 | 6 | IPR019734 | |
| Domain | Munc13_dom-2 | 5.65e-04 | 5 | 142 | 2 | IPR014772 | |
| Domain | MHD2 | 5.65e-04 | 5 | 142 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 5.65e-04 | 5 | 142 | 2 | IPR019558 | |
| Domain | Membr_traf_MHD | 5.65e-04 | 5 | 142 | 2 | PF10540 | |
| Domain | - | 5.65e-04 | 5 | 142 | 2 | 1.10.287.160 | |
| Domain | TPR_1 | 6.20e-04 | 90 | 142 | 5 | IPR001440 | |
| Domain | TPR_1 | 6.20e-04 | 90 | 142 | 5 | PF00515 | |
| Domain | C2 | 6.31e-04 | 137 | 142 | 6 | SM00239 | |
| Domain | Nuc_rcpt_coact | 8.44e-04 | 6 | 142 | 2 | IPR009110 | |
| Domain | HR1_rho-bd | 8.75e-04 | 25 | 142 | 3 | IPR011072 | |
| Domain | - | 9.46e-04 | 148 | 142 | 6 | 2.60.40.150 | |
| Domain | TPR-contain_dom | 1.01e-03 | 150 | 142 | 6 | IPR013026 | |
| Domain | - | 1.05e-03 | 207 | 142 | 7 | 1.25.40.10 | |
| Domain | ARM-type_fold | 1.16e-03 | 339 | 142 | 9 | IPR016024 | |
| Domain | Hr1 | 1.18e-03 | 7 | 142 | 2 | SM00742 | |
| Domain | CHCR | 1.18e-03 | 7 | 142 | 2 | PS50236 | |
| Domain | Clathrin_H-chain/VPS_repeat | 1.56e-03 | 8 | 142 | 2 | IPR000547 | |
| Domain | HR1 | 1.56e-03 | 8 | 142 | 2 | PF02185 | |
| Domain | TPR_REGION | 1.65e-03 | 165 | 142 | 6 | PS50293 | |
| Domain | TPR | 1.65e-03 | 165 | 142 | 6 | PS50005 | |
| Domain | GST_N_3 | 2.00e-03 | 9 | 142 | 2 | PF13417 | |
| Domain | TPR-like_helical_dom | 2.06e-03 | 233 | 142 | 7 | IPR011990 | |
| Domain | C2 | 4.62e-03 | 142 | 142 | 5 | PS50004 | |
| Domain | G_DYNAMIN_dom | 4.92e-03 | 14 | 142 | 2 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 4.92e-03 | 14 | 142 | 2 | PS51718 | |
| Domain | Dynamin_GTPase | 5.65e-03 | 15 | 142 | 2 | IPR001401 | |
| Domain | Dynamin_SF | 5.65e-03 | 15 | 142 | 2 | IPR022812 | |
| Domain | Dynamin_N | 5.65e-03 | 15 | 142 | 2 | PF00350 | |
| Domain | CNH | 5.65e-03 | 15 | 142 | 2 | PF00780 | |
| Domain | CNH | 5.65e-03 | 15 | 142 | 2 | PS50219 | |
| Domain | CNH_dom | 5.65e-03 | 15 | 142 | 2 | IPR001180 | |
| Domain | - | 7.07e-03 | 222 | 142 | 6 | 1.25.10.10 | |
| Pathway | WP_ESTROGEN_SIGNALING | 3.08e-05 | 23 | 113 | 4 | M39672 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 4.07e-05 | 257 | 113 | 10 | MM14755 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_RECYCLING | 9.13e-05 | 30 | 113 | 4 | M506 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 1.04e-04 | 31 | 113 | 4 | M213 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_RECYCLING | 1.04e-04 | 31 | 113 | 4 | MM15467 | |
| Pathway | PID_MAPK_TRK_PATHWAY | 1.51e-04 | 34 | 113 | 4 | M270 | |
| Pathway | WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING | 1.83e-04 | 66 | 113 | 5 | M39684 | |
| Pathway | REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES | 1.89e-04 | 36 | 113 | 4 | M26923 | |
| Pathway | BIOCARTA_CDMAC_PATHWAY | 2.13e-04 | 15 | 113 | 3 | MM1358 | |
| Pathway | REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES | 2.34e-04 | 38 | 113 | 4 | MM14519 | |
| Pathway | BIOCARTA_CDMAC_PATHWAY | 2.60e-04 | 16 | 113 | 3 | M4388 | |
| Pathway | WP_PDGF_PATHWAY | 2.86e-04 | 40 | 113 | 4 | M39555 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | SPTBN1 BAG4 KAT2A CREB1 IQGAP1 CHUK AKAP9 PSME4 MAP2K1 EP300 GOLGA4 GOLGB1 | 3.41e-04 | 464 | 113 | 12 | M27547 |
| Pathway | WP_LEPTIN_SIGNALING | 3.56e-04 | 76 | 113 | 5 | M39491 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 3.56e-04 | 76 | 113 | 5 | MM15442 | |
| Pathway | WP_ESTROGEN_SIGNALING | 3.78e-04 | 77 | 113 | 5 | MM15934 | |
| Pathway | WP_IL11_SIGNALING | 4.15e-04 | 44 | 113 | 4 | M39716 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY | 4.43e-04 | 19 | 113 | 3 | M47853 | |
| Pubmed | NAA15 NUP107 VEZT RPAP3 SPTBN1 BAG4 RPS13 PREPL EHD4 EFR3A MRPS10 AKAP9 ANO6 MTIF2 GKAP1 ASPM EHMT1 EMG1 PLEKHA5 PKN2 SEC63 MAP2K1 SMCR8 DEK ACBD3 GOLGA4 GOLGB1 ATP6V0A2 | 3.21e-11 | 1487 | 148 | 28 | 33957083 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 NUP107 SPTBN1 RPS13 ABCF2 IDE IQGAP1 EHD4 FANCD2 SLC38A1 ATP6V1H GUCY1B2 VPS33B MAGED2 ANAPC1 FANCI EHMT1 UTP20 CCAR2 EEA1 SEC63 DDX41 DEK GOLGA4 KIF11 | 1.79e-09 | 1425 | 148 | 25 | 30948266 |
| Pubmed | CCNL2 USP34 ARID4B NUP107 VEZT BAG4 KAT2A ZNF518A FANCD2 JAK1 FAT1 HMCN2 ANAPC1 MTIF2 PIP4K2A CAPRIN2 ASPM EHMT1 CSMD1 DDX41 VPS53 EP300 | 2.32e-09 | 1116 | 148 | 22 | 31753913 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | NUP107 ORC3 SPTBN1 IQGAP1 EHD4 FANCD2 DOCK5 NDC80 VPS33B MAGED2 ANAPC1 FANCI PKN2 DDX41 GOLGB1 KIF11 | 4.40e-09 | 582 | 148 | 16 | 20467437 |
| Pubmed | USP34 NUP107 CCDC186 RUFY1 SLC38A1 DOCK5 FAT1 SLC30A5 MAGED2 ANO6 EHMT1 CCAR2 SMCR8 TASOR GOLGA4 GOLGB1 ATP6V0A2 | 4.03e-08 | 777 | 148 | 17 | 35844135 | |
| Pubmed | RPAP3 SPTBN1 RPS13 ABCF2 IQGAP1 EFR3A SLC38A1 ATP6V1H MAGED2 FANCI PLEKHA5 PKN2 SEC63 SMCR8 GOLGA4 GOLGB1 | 6.67e-08 | 708 | 148 | 16 | 39231216 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NAA15 NUP107 RPAP3 SPTBN1 RPS13 ABCF2 TSC1 IQGAP1 EHD4 PSME4 VPS33B MAGED2 FANCI PIP4K2A ASPM UTP20 PLEKHA5 CCAR2 PKN2 DDX41 GOLGA4 KIF11 | 7.16e-08 | 1353 | 148 | 22 | 29467282 |
| Pubmed | USP34 VPS39 MARK1 SPTBN1 RALGPS2 AKNAD1 XPA COPS2 SPAG5 CEP63 PSME4 VPS33B DZIP3 SEC63 TASOR HERC4 GOLGB1 KIF11 ATP6V0A2 | 1.95e-07 | 1084 | 148 | 19 | 11544199 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | NUP107 ORC3 SPTBN1 IQGAP1 EHD4 ANAPC1 EHMT1 EMG1 CCAR2 PKN2 KIF11 | 2.03e-07 | 332 | 148 | 11 | 32786267 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CFAP91 NUP107 RPAP3 TTC21A RALGPS2 RPS13 COPS2 SPAG5 IQGAP1 DOCK5 FANCB MAGED2 GKAP1 DZIP3 PLEKHA5 CCAR2 EEA1 DDX41 VPS53 PKN3 PMFBP1 | 2.13e-07 | 1321 | 148 | 21 | 27173435 |
| Pubmed | KNTC1 SPTBN1 ABCF2 TSC1 KAT2A UBLCP1 IQGAP1 CHUK EHD4 KRT23 MAGED2 SNX25 PIP4K2A CAPRIN2 ASPM CCAR2 PADI6 EEA1 CADPS2 TASOR GOLGB1 KIF11 | 2.14e-07 | 1442 | 148 | 22 | 35575683 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 USP34 ATP6V1C1 NAA15 SPTBN1 RPS13 ABCF2 IDE COPS2 RUFY1 IQGAP1 CHUK EHD4 FANCD2 ATP6V1H PSME4 MAGED2 FANCI CCAR2 DEK ACBD3 HERC4 | 2.49e-07 | 1455 | 148 | 22 | 22863883 |
| Pubmed | 3.19e-07 | 210 | 148 | 9 | 16565220 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | NAA15 NUP107 VEZT RPAP3 TSC1 IDE PREPL MFN1 EHD4 FANCD2 MRPS10 AKAP9 NDC80 VPS33B MAGED2 MTIF2 CCAR2 SEC63 DDX41 SMCR8 ACBD3 GOLGB1 | 3.98e-07 | 1496 | 148 | 22 | 32877691 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KNTC1 HSD17B7 NAA15 NUP107 ORC3 IDE COPS2 SPAG5 IQGAP1 CEP63 FANCB NDC80 ANAPC1 ASPM EHMT1 BTG3 CCAR2 EEA1 DDX41 | 5.10e-07 | 1155 | 148 | 19 | 20360068 |
| Pubmed | NUP107 VEZT RPAP3 SPTBN1 TSC1 IDE UBLCP1 EHD4 EFR3A FANCD2 SLC38A1 TTC7B AKAP9 VPS33B FANCI CCAR2 DEK GOLGA4 | 5.71e-07 | 1049 | 148 | 18 | 27880917 | |
| Pubmed | CCNL2 USP34 CFAP91 BAG4 IDE UBLCP1 GPR179 JAK1 STMN4 PSME4 IL1RAPL2 IFIT1B CENPI CSMD1 SEC63 KIF11 | 5.78e-07 | 832 | 148 | 16 | 36724073 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NAA15 NUP107 VEZT JAGN1 BAG4 ABCF2 SPAG5 IQGAP1 FANCD2 ATP6V1H MAGED2 FANCI UTP20 SEC63 ACBD3 VPS53 KIF11 | 6.05e-07 | 942 | 148 | 17 | 31073040 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 DPY19L3 VEZT VPS39 JAGN1 BAG4 FANCD2 DOCK5 JAK1 FAT1 HOOK3 SLC30A5 ANO6 FANCI CCAR2 EEA1 GOLGB1 ATP6V0A2 | 6.72e-07 | 1061 | 148 | 18 | 33845483 |
| Pubmed | SPTBN1 TSC1 PREPL IQGAP1 HOOK3 AKAP9 MAGED2 ANAPC1 DZIP3 EHMT1 PLCB1 PLEKHA5 CCAR2 UNC13A GOLGA4 GOLGB1 KIF11 | 8.18e-07 | 963 | 148 | 17 | 28671696 | |
| Pubmed | VEZT JAGN1 SPTBN1 TSC1 RUFY1 SLC38A1 SLC30A5 VPS33B ANO6 SEC63 ACBD3 FMNL1 GOLGA4 | 1.05e-06 | 568 | 148 | 13 | 37774976 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | KNTC1 IDE ZNF518A MAGED2 PIP4K2A NCOA1 MYO15A SMCR8 EP300 KIF11 TANGO6 | 1.21e-06 | 398 | 148 | 11 | 35016035 |
| Pubmed | 1.41e-06 | 251 | 148 | 9 | 29778605 | ||
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 1.43e-06 | 186 | 148 | 8 | 33637726 | |
| Pubmed | Munc13-1 and Munc18-1 together prevent NSF-dependent de-priming of synaptic vesicles. | 1.50e-06 | 6 | 148 | 3 | 28635948 | |
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 10497212 | ||
| Pubmed | 1.78e-06 | 21 | 148 | 4 | 19596656 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CCNL2 USP34 RASSF2 JAGN1 MARK1 CCDC186 CHUK JAK1 AKAP9 ANAPC1 PIP4K2A PKN2 DDX41 MAP2K1 DEK EP300 | 1.85e-06 | 910 | 148 | 16 | 36736316 |
| Pubmed | USP34 NUP107 RPAP3 RUFY1 SPAG5 ANAPC1 PLEKHA5 TASOR GOLGB1 KIF11 TANGO6 | 1.94e-06 | 418 | 148 | 11 | 34709266 | |
| Pubmed | TSC1 RUFY1 EHD4 SLC38A1 VPS33B SMCR8 ACBD3 FMNL1 GOLGA4 GOLGB1 | 2.10e-06 | 339 | 148 | 10 | 37232246 | |
| Pubmed | CCNL2 HSD17B7 ARID4B VPS39 TSC1 KAT2A CHKA RUFY1 CREB1 PREPL FANCD2 ANAPC1 CENPI ASPM NCOA1 SEC63 EP300 RBM18 ATP6V0A2 | 3.91e-06 | 1327 | 148 | 19 | 32694731 | |
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 4.16e-06 | 8 | 148 | 3 | 25609709 | |
| Pubmed | NUP107 VPS39 CCDC186 SPTBN1 DOCK5 SLC9A2 EHMT1 EMG1 SEC63 TASOR ACBD3 EP300 GOLGB1 TANGO6 | 4.56e-06 | 754 | 148 | 14 | 35906200 | |
| Pubmed | NAA15 RPAP3 ABCF2 MFN1 SPAG5 EHD4 CCAR2 PKN2 EEA1 SEC63 DDX41 EP300 KIF11 | 4.82e-06 | 653 | 148 | 13 | 33742100 | |
| Pubmed | Mammalian CORVET is required for fusion and conversion of distinct early endosome subpopulations. | 6.23e-06 | 9 | 148 | 3 | 25266290 | |
| Pubmed | USP34 ORC3 XPA KAT2A COPS2 UBLCP1 IQGAP1 FANCD2 ANAPC1 FANCI EHMT1 CCAR2 MYO15A DDX41 DEK EP300 | 7.28e-06 | 1014 | 148 | 16 | 32416067 | |
| Pubmed | ARID4B CCDC186 FOS SPTBN1 CREB1 KRT23 PLCB1 PLEKHA5 MAP2K1 EP300 GOLGB1 | 8.12e-06 | 486 | 148 | 11 | 20936779 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | ATP6V1C1 VPS39 FANCD2 JAK1 ATP6V1H MAGED2 FANCI PKN3 ATP6V0A2 | 8.47e-06 | 313 | 148 | 9 | 38270169 |
| Pubmed | SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming. | 8.87e-06 | 10 | 148 | 3 | 21040848 | |
| Pubmed | 8.87e-06 | 10 | 148 | 3 | 26463206 | ||
| Pubmed | UNC13B USP34 CFAP91 VPS39 SPTBN1 PREPL IQGAP1 FN3K CHUK CEP63 JAK1 GDAP1L1 TTC7B MTIF2 BTG3 CADPS2 ACBD3 EP300 | 9.65e-06 | 1285 | 148 | 18 | 35914814 | |
| Pubmed | UNC13B JAGN1 SPTBN1 GDAP1 NCF2 NUDT9 RUFY1 EHD4 FANCB FAT1 GDAP1L1 MTIF2 EMG1 EEA1 CSMD1 CADPS2 SMCR8 GOLGB1 | 1.05e-05 | 1293 | 148 | 18 | 15342556 | |
| Pubmed | The morphological and molecular nature of synaptic vesicle priming at presynaptic active zones. | 1.22e-05 | 11 | 148 | 3 | 25374362 | |
| Pubmed | The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. | 1.22e-05 | 11 | 148 | 3 | 19965384 | |
| Pubmed | KNTC1 USP34 SPTBN1 ABCF2 COPS2 SPAG5 IQGAP1 CHUK EHD4 FANCD2 MRPS10 ATP6V1H HOOK3 FANCI CCAR2 SEC63 DDX41 DEK VPS53 | 1.24e-05 | 1440 | 148 | 19 | 30833792 | |
| Pubmed | 1.31e-05 | 120 | 148 | 6 | 27320910 | ||
| Pubmed | MARK1 SLC38A1 SLC30A5 TTC7B VPS33B PLCB1 PLEKHA5 SEC63 ACBD3 GOLGB1 | 1.40e-05 | 421 | 148 | 10 | 36976175 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.50e-05 | 256 | 148 | 8 | 33397691 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 26514923 | ||
| Pubmed | KNTC1 USP34 VEZT RPAP3 TSC1 ANAPC1 PLEKHA5 CCAR2 SEC63 TASOR ACBD3 GOLGA4 PKN3 | 1.64e-05 | 733 | 148 | 13 | 34672954 | |
| Pubmed | USP34 VPS39 PREPL IQGAP1 EFR3A PSME4 CAPRIN2 EHMT1 PLCB1 PLEKHA5 HERC4 | 1.78e-05 | 529 | 148 | 11 | 14621295 | |
| Pubmed | DNA clamp function of the monoubiquitinated Fanconi anaemia ID complex. | 1.80e-05 | 2 | 148 | 2 | 32269332 | |
| Pubmed | FANCI functions as a repair/apoptosis switch in response to DNA crosslinks. | 1.80e-05 | 2 | 148 | 2 | 34256011 | |
| Pubmed | FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures. | 1.80e-05 | 2 | 148 | 2 | 19561358 | |
| Pubmed | Activation of RASSF2A by p300 induces late apoptosis through histone hyperacetylation. | 1.80e-05 | 2 | 148 | 2 | 20716062 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12871971 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 17561838 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20961651 | ||
| Pubmed | ASPM promotes migration and invasion of anaplastic thyroid carcinoma by stabilizing KIF11. | 1.80e-05 | 2 | 148 | 2 | 36883909 | |
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 1.80e-05 | 2 | 148 | 2 | 28489077 | |
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 1.80e-05 | 2 | 148 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 1.80e-05 | 2 | 148 | 2 | 22066784 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 28636932 | ||
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 1.80e-05 | 2 | 148 | 2 | 32187536 | |
| Pubmed | Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. | 1.80e-05 | 2 | 148 | 2 | 19465922 | |
| Pubmed | Expression and purification of human FANCI and FANCD2 using Escherichia coli cells. | 1.80e-05 | 2 | 148 | 2 | 25168188 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22814762 | ||
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 1.80e-05 | 2 | 148 | 2 | 28426965 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23770256 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24278431 | ||
| Pubmed | FANCD2-FANCI surveys DNA and recognizes double- to single-stranded junctions. | 1.80e-05 | 2 | 148 | 2 | 39085614 | |
| Pubmed | Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance. | 1.80e-05 | 2 | 148 | 2 | 38565741 | |
| Pubmed | GCN5-dependent acetylation of HIV-1 integrase enhances viral integration. | 1.80e-05 | 2 | 148 | 2 | 20226045 | |
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 1.80e-05 | 2 | 148 | 2 | 31851910 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 32725171 | ||
| Pubmed | Mechanism, specificity, and function of FANCD2-FANCI ubiquitination and deubiquitination. | 1.80e-05 | 2 | 148 | 2 | 34137174 | |
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 1.80e-05 | 2 | 148 | 2 | 11832228 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 1.80e-05 | 2 | 148 | 2 | 23229896 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 30201979 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27773793 | ||
| Pubmed | FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2. | 1.80e-05 | 2 | 148 | 2 | 26430909 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12070347 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 32167469 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23070049 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 29059323 | ||
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 1.80e-05 | 2 | 148 | 2 | 28772123 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 1.80e-05 | 2 | 148 | 2 | 17267576 | |
| Pubmed | FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. | 1.80e-05 | 2 | 148 | 2 | 17460694 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11590181 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27405460 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 35613050 | ||
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 1.80e-05 | 2 | 148 | 2 | 30816091 | |
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 1.80e-05 | 2 | 148 | 2 | 19558619 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18701688 | ||
| Pubmed | Structure of the FANCI-FANCD2 complex: insights into the Fanconi anemia DNA repair pathway. | 1.80e-05 | 2 | 148 | 2 | 21764741 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11792326 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31552299 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 33893273 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15858821 | ||
| Pubmed | NAA15 RASSF2 TSC1 IQGAP1 MAGED2 FANCI TGFBRAP1 DZIP3 CCAR2 SMCR8 | 1.93e-05 | 437 | 148 | 10 | 20562859 | |
| Interaction | LAMP2 interactions | VEZT SPTBN1 TSC1 RUFY1 EFR3A SLC38A1 JAK1 ATP6V1H SLC30A5 ANO6 PLCB1 EEA1 SMCR8 ACBD3 VPS53 EP300 GOLGA4 GOLGB1 ATP6V0A2 | 1.13e-07 | 609 | 148 | 19 | int:LAMP2 |
| Interaction | WHAMMP3 interactions | 2.37e-07 | 119 | 148 | 9 | int:WHAMMP3 | |
| Interaction | RAC2 interactions | VEZT SPTBN1 NCF2 RUFY1 IQGAP1 EFR3A FANCD2 SLC38A1 DOCK5 FAT1 SLC30A5 ANO6 UTP20 PLEKHA5 PKN2 ACBD3 FMNL1 GOLGA4 GOLGB1 | 5.33e-07 | 674 | 148 | 19 | int:RAC2 |
| Interaction | KRT38 interactions | CCDC186 TSC1 ANKRD36BP1 CREB1 SPAG5 CEP63 ASPM EEA1 VPS53 PKN3 | 5.83e-07 | 172 | 148 | 10 | int:KRT38 |
| Interaction | LAMP3 interactions | KNTC1 VEZT SPTBN1 TSC1 EFR3A SLC38A1 JAK1 SLC30A5 ANO6 FANCI EEA1 SMCR8 ACBD3 VPS53 GOLGA4 GOLGB1 | 6.02e-07 | 486 | 148 | 16 | int:LAMP3 |
| Interaction | RHOG interactions | SPTBN1 TSC1 RUFY1 PREPL IQGAP1 EFR3A FANCD2 SLC38A1 DOCK5 JAK1 MRPS10 FAT1 VPS33B ANO6 MTIF2 PLEKHA5 PKN2 SMCR8 ACBD3 FMNL1 GOLGA4 GOLGB1 | 8.46e-07 | 910 | 148 | 22 | int:RHOG |
| Interaction | RAB2A interactions | VEZT SPTBN1 TSC1 RUFY1 IQGAP1 EFR3A FANCD2 SLC38A1 ATP6V1H SLC30A5 ANO6 PLCB1 ACBD3 VPS53 EP300 GOLGA4 GOLGB1 | 9.57e-07 | 567 | 148 | 17 | int:RAB2A |
| Interaction | RHOH interactions | SPTBN1 TSC1 RUFY1 EHD4 EFR3A SLC38A1 JAK1 TTC7B VPS33B PLEKHA5 PKN2 SMCR8 ACBD3 FMNL1 GOLGA4 GOLGB1 | 1.19e-06 | 512 | 148 | 16 | int:RHOH |
| Interaction | CDC5L interactions | NUP107 ORC3 SPTBN1 ABCF2 XPA COPS2 IQGAP1 EHD4 FANCD2 DOCK5 AKAP9 NDC80 VPS33B ANAPC1 FANCI DZIP3 PKN2 DDX41 EP300 GOLGB1 KIF11 | 1.20e-06 | 855 | 148 | 21 | int:CDC5L |
| Interaction | RAB4A interactions | VEZT TSC1 RUFY1 SLC38A1 VPS33B ANO6 PIP4K2A PLEKHA5 EEA1 SMCR8 ACBD3 VPS53 FMNL1 GOLGA4 GOLGB1 | 1.43e-06 | 457 | 148 | 15 | int:RAB4A |
| Interaction | LAMTOR1 interactions | MARK1 CCDC186 SPTBN1 TSC1 RUFY1 IQGAP1 EHD4 EFR3A FANCD2 SLC38A1 VPS33B PLEKHA5 EEA1 SMCR8 ACBD3 VPS53 GOLGA4 GOLGB1 ATP6V0A2 | 1.49e-06 | 722 | 148 | 19 | int:LAMTOR1 |
| Interaction | EID1 interactions | 1.94e-06 | 51 | 148 | 6 | int:EID1 | |
| Interaction | RAB5C interactions | VEZT JAGN1 SPTBN1 TSC1 COPS2 RUFY1 FANCD2 SLC38A1 SLC30A5 ANO6 EEA1 MAP2K1 SMCR8 ACBD3 VPS53 EP300 GOLGB1 | 2.07e-06 | 600 | 148 | 17 | int:RAB5C |
| Interaction | RHOF interactions | MARK1 SPTBN1 RPS13 IQGAP1 EHD4 EFR3A SLC38A1 FAT1 TTC7B ANO6 FANCI UTP20 PLEKHA5 PKN2 MAP2K1 ACBD3 FMNL1 GOLGB1 | 2.29e-06 | 673 | 148 | 18 | int:RHOF |
| Interaction | OPALIN interactions | KNTC1 EFR3A FANCD2 DOCK5 JAK1 ATP6V1H SLC30A5 FANCI UTP20 PKN3 | 3.41e-06 | 209 | 148 | 10 | int:OPALIN |
| Interaction | SYCE1 interactions | 4.49e-06 | 127 | 148 | 8 | int:SYCE1 | |
| Interaction | RHOD interactions | SPTBN1 RUFY1 IQGAP1 EHD4 EFR3A SLC38A1 VPS33B ANO6 UTP20 PLEKHA5 PKN2 SEC63 MAP2K1 FMNL1 GOLGA4 GOLGB1 | 4.95e-06 | 572 | 148 | 16 | int:RHOD |
| Interaction | KCNA3 interactions | RPAP3 ABCA13 SPTBN1 AKNAD1 RPS13 ABCF2 IQGAP1 EFR3A SLC38A1 ATP6V1H MAGED2 FANCI CAPRIN2 PLEKHA5 PKN2 SEC63 SMCR8 GOLGA4 GOLGB1 KIF11 | 6.07e-06 | 871 | 148 | 20 | int:KCNA3 |
| Interaction | STX7 interactions | VEZT JAGN1 SPTBN1 TSC1 RUFY1 EHD4 SLC38A1 VPS33B ANO6 PLEKHA5 EEA1 SEC63 SMCR8 ACBD3 VPS53 GOLGA4 GOLGB1 | 7.18e-06 | 659 | 148 | 17 | int:STX7 |
| Interaction | PHF21A interactions | USP34 NUP107 RPAP3 RUFY1 SPAG5 ANAPC1 DZIP3 PLEKHA5 VPS53 GOLGB1 PKN3 TANGO6 | 8.97e-06 | 343 | 148 | 12 | int:PHF21A |
| Interaction | SNW1 interactions | VPS39 ORC3 SPTBN1 BAG4 ABCF2 IQGAP1 EHD4 FANCD2 NDC80 VPS33B MAGED2 ANAPC1 FANCI NCOA1 PKN2 DDX41 EP300 KIF11 | 9.64e-06 | 747 | 148 | 18 | int:SNW1 |
| Interaction | BRCA1 interactions | CCNL2 KNTC1 NAA15 NUP107 RPAP3 ORC3 SPTBN1 RPS13 ABCF2 RUFY1 CREB1 SPAG5 IQGAP1 FANCD2 JAK1 FANCB ATP6V1H FANCI CENPI DZIP3 NCOA1 CCAR2 EP300 KIF11 | 1.36e-05 | 1249 | 148 | 24 | int:BRCA1 |
| Interaction | EBAG9 interactions | CHUK EFR3A SLC38A1 HOOK3 SLC30A5 PLEKHA5 SMCR8 ACBD3 VPS53 GOLGA4 GOLGB1 | 1.52e-05 | 303 | 148 | 11 | int:EBAG9 |
| Interaction | KDM1A interactions | USP34 NUP107 RPAP3 RASSF2 TSC1 COPS2 RUFY1 SPAG5 FANCD2 AKAP9 ANAPC1 DZIP3 EHMT1 PLEKHA5 TASOR VPS53 EP300 GOLGB1 KIF11 TANGO6 | 1.87e-05 | 941 | 148 | 20 | int:KDM1A |
| Interaction | CEP170P1 interactions | 2.01e-05 | 113 | 148 | 7 | int:CEP170P1 | |
| Interaction | RHOA interactions | VEZT SPTBN1 RUFY1 IQGAP1 EFR3A FANCD2 SLC38A1 JAK1 FAT1 SLC30A5 ANO6 UTP20 PLEKHA5 PKN2 SEC63 MAP2K1 SMCR8 ACBD3 FMNL1 GOLGA4 GOLGB1 PKN3 ATP6V0A2 | 2.16e-05 | 1199 | 148 | 23 | int:RHOA |
| Interaction | RAB35 interactions | VEZT MARK1 SPTBN1 RUFY1 IQGAP1 EFR3A FANCD2 SLC38A1 ANO6 PLCB1 PLEKHA5 SEC63 SMCR8 ACBD3 GOLGB1 | 2.16e-05 | 573 | 148 | 15 | int:RAB35 |
| Interaction | FBXO42 interactions | NUP107 RPS13 TSC1 COPS2 RUFY1 NDC80 ANAPC1 PIP4K2A ASPM GOLGB1 | 2.23e-05 | 259 | 148 | 10 | int:FBXO42 |
| Interaction | RND2 interactions | SPTBN1 RUFY1 EFR3A SLC38A1 JAK1 UTP20 PLEKHA5 PKN2 SMCR8 ACBD3 FMNL1 GOLGA4 GOLGB1 | 2.27e-05 | 440 | 148 | 13 | int:RND2 |
| Interaction | HIF1A interactions | FOS ABCF2 CREB1 ZNF518A IQGAP1 FAT1 FBXO8 FANCI GKAP1 NCOA1 PLEKHA5 CCAR2 EP300 | 2.32e-05 | 441 | 148 | 13 | int:HIF1A |
| Interaction | BIRC3 interactions | KNTC1 NUP107 SPTBN1 RPS13 ABCF2 IDE IQGAP1 CHUK EHD4 FANCD2 ATP6V1H MAGED2 FANCI DZIP3 EHMT1 UTP20 CCAR2 EEA1 SEC63 DDX41 DEK EP300 GOLGA4 KIF11 | 3.95e-05 | 1334 | 148 | 24 | int:BIRC3 |
| Interaction | TPTE interactions | 4.73e-05 | 129 | 148 | 7 | int:TPTE | |
| Interaction | CCND1 interactions | 5.16e-05 | 286 | 148 | 10 | int:CCND1 | |
| Interaction | ANAPC2 interactions | 5.95e-05 | 234 | 148 | 9 | int:ANAPC2 | |
| Interaction | VPS18 interactions | 6.32e-05 | 135 | 148 | 7 | int:VPS18 | |
| Interaction | LURAP1 interactions | 6.93e-05 | 137 | 148 | 7 | int:LURAP1 | |
| Interaction | LAMP1 interactions | VEZT SPTBN1 IQGAP1 EHD4 EFR3A SLC38A1 SLC30A5 VPS33B PIP4K2A PLCB1 PLEKHA5 PKN2 SEC63 ACBD3 GOLGB1 | 8.16e-05 | 644 | 148 | 15 | int:LAMP1 |
| Interaction | CDC16 interactions | 8.74e-05 | 246 | 148 | 9 | int:CDC16 | |
| Interaction | KRT37 interactions | 9.58e-05 | 100 | 148 | 6 | int:KRT37 | |
| Interaction | MAX interactions | 1.02e-04 | 251 | 148 | 9 | int:MAX | |
| Interaction | RPS6KA2 interactions | 1.02e-04 | 196 | 148 | 8 | int:RPS6KA2 | |
| Interaction | ARF6 interactions | ATP6V1C1 VEZT SPTBN1 KAT2A IQGAP1 EFR3A FANCD2 SLC38A1 FBXO8 ANO6 PLCB1 PLEKHA5 SEC63 ACBD3 | 1.05e-04 | 584 | 148 | 14 | int:ARF6 |
| Interaction | RHOQ interactions | SPTBN1 RUFY1 IQGAP1 EFR3A SLC38A1 JAK1 FAT1 SLC30A5 PLEKHA5 SMCR8 ACBD3 GOLGB1 | 1.06e-04 | 442 | 148 | 12 | int:RHOQ |
| Interaction | SKAP1 interactions | 1.07e-04 | 102 | 148 | 6 | int:SKAP1 | |
| Interaction | VPS41 interactions | 1.07e-04 | 64 | 148 | 5 | int:VPS41 | |
| Interaction | SUMO2 interactions | NUP107 ORC3 FOS SPTBN1 IQGAP1 EHD4 FANCD2 ANAPC1 EHMT1 EMG1 CCAR2 PKN2 EP300 KIF11 | 1.19e-04 | 591 | 148 | 14 | int:SUMO2 |
| Interaction | STX6 interactions | VEZT SPTBN1 TSC1 SLC38A1 VPS33B PLEKHA5 EEA1 SMCR8 ACBD3 VPS53 GOLGA4 GOLGB1 | 1.20e-04 | 448 | 148 | 12 | int:STX6 |
| Interaction | RAB9A interactions | VEZT TSC1 RUFY1 FANCD2 SLC38A1 ANO6 PLEKHA5 EEA1 SEC63 SMCR8 ACBD3 VPS53 GOLGA4 GOLGB1 | 1.28e-04 | 595 | 148 | 14 | int:RAB9A |
| Interaction | RAB11A interactions | VEZT SPTBN1 TSC1 RUFY1 EHD4 EFR3A FANCD2 SLC38A1 VPS33B ANO6 PLEKHA5 SMCR8 ACBD3 VPS53 FMNL1 GOLGA4 GOLGB1 | 1.30e-04 | 830 | 148 | 17 | int:RAB11A |
| Interaction | CENPE interactions | 1.32e-04 | 106 | 148 | 6 | int:CENPE | |
| Interaction | GJD3 interactions | VEZT SPTBN1 EFR3A SLC38A1 SLC30A5 ANO6 PLEKHA5 SEC63 SMCR8 ACBD3 GOLGA4 GOLGB1 | 1.36e-04 | 454 | 148 | 12 | int:GJD3 |
| Interaction | TRIM66 interactions | 1.40e-04 | 205 | 148 | 8 | int:TRIM66 | |
| Interaction | PSMD3 interactions | NAA15 RPS13 RUFY1 UBLCP1 IQGAP1 FANCD2 PSME4 VPS33B CCAR2 EP300 GOLGA4 | 1.48e-04 | 390 | 148 | 11 | int:PSMD3 |
| Interaction | BTNL9 interactions | 1.56e-04 | 156 | 148 | 7 | int:BTNL9 | |
| Interaction | ADRM1 interactions | 1.58e-04 | 266 | 148 | 9 | int:ADRM1 | |
| Interaction | IGF1R interactions | VEZT ABCF2 TSC1 FANCD2 JAK1 FANCI PLEKHA5 EEA1 SEC63 MAP2K1 ACBD3 EP300 | 1.77e-04 | 467 | 148 | 12 | int:IGF1R |
| Interaction | PHLPP1 interactions | RPAP3 ABCF2 TSC1 SPAG5 EFR3A FANCI ASPM PLEKHA5 GOLGB1 KIF11 | 1.80e-04 | 333 | 148 | 10 | int:PHLPP1 |
| Interaction | TGFBR2 interactions | 2.02e-04 | 275 | 148 | 9 | int:TGFBR2 | |
| Interaction | CTBP1 interactions | KAT2A ZNF518A EHD4 FANCD2 SLC30A5 AKAP9 DZIP3 EHMT1 PLCB1 VPS53 EP300 | 2.10e-04 | 406 | 148 | 11 | int:CTBP1 |
| Interaction | EP300 interactions | NAA15 RPAP3 FOS ABCF2 XPA KAT2A COPS2 CREB1 MFN1 SPAG5 CHUK EHD4 SLC30A5 NCOA1 CCAR2 PKN2 EEA1 SEC63 DDX41 MAP2K1 DEK EP300 KIF11 | 2.28e-04 | 1401 | 148 | 23 | int:EP300 |
| Interaction | GPR17 interactions | 2.50e-04 | 283 | 148 | 9 | int:GPR17 | |
| Interaction | CDC42 interactions | NAA15 VEZT SPTBN1 NCF2 RUFY1 IQGAP1 EHD4 EFR3A FANCD2 SLC38A1 JAK1 FAT1 ATP6V1H VPS33B ANO6 UTP20 PLEKHA5 PKN2 DEK ACBD3 FMNL1 GOLGB1 | 2.65e-04 | 1323 | 148 | 22 | int:CDC42 |
| Interaction | RAC1 interactions | SPTBN1 NCF2 TSC1 RUFY1 IQGAP1 EHD4 EFR3A FANCD2 SLC38A1 DOCK5 JAK1 FAT1 ANO6 PIP4K2A UTP20 PLEKHA5 PKN2 MAP2K1 FMNL1 | 2.97e-04 | 1063 | 148 | 19 | int:RAC1 |
| Interaction | MAGED1 interactions | 3.39e-04 | 295 | 148 | 9 | int:MAGED1 | |
| Interaction | GMFG interactions | 3.45e-04 | 19 | 148 | 3 | int:GMFG | |
| Interaction | KLHL10 interactions | 3.59e-04 | 46 | 148 | 4 | int:KLHL10 | |
| Interaction | CYBB interactions | 3.59e-04 | 46 | 148 | 4 | int:CYBB | |
| Interaction | NCOR1 interactions | 3.59e-04 | 363 | 148 | 10 | int:NCOR1 | |
| Interaction | H2AC4 interactions | ORC3 SPTBN1 IDE KAT2A EHD4 FANCD2 ANAPC1 DZIP3 EEA1 DDX41 EP300 KIF11 | 3.66e-04 | 506 | 148 | 12 | int:H2AC4 |
| Interaction | PEX14 interactions | 3.73e-04 | 237 | 148 | 8 | int:PEX14 | |
| Interaction | GAPVD1 interactions | 3.74e-04 | 180 | 148 | 7 | int:GAPVD1 | |
| Interaction | GJA1 interactions | VEZT MARK1 SPTBN1 EFR3A SLC38A1 SLC30A5 ANO6 PLEKHA5 SMCR8 ACBD3 GOLGA4 GOLGB1 KIF11 | 3.76e-04 | 583 | 148 | 13 | int:GJA1 |
| Interaction | PFN1 interactions | KNTC1 SPTBN1 TSC1 RUFY1 SPAG5 FANCD2 AKAP9 PLEKHA5 FMNL1 GOLGA4 GOLGB1 KIF11 | 3.86e-04 | 509 | 148 | 12 | int:PFN1 |
| Interaction | ZWILCH interactions | 3.90e-04 | 47 | 148 | 4 | int:ZWILCH | |
| Interaction | DZIP3 interactions | 4.14e-04 | 183 | 148 | 7 | int:DZIP3 | |
| Interaction | RABEP1 interactions | 4.27e-04 | 184 | 148 | 7 | int:RABEP1 | |
| Interaction | AHR interactions | 4.34e-04 | 132 | 148 | 6 | int:AHR | |
| Interaction | RHOV interactions | 4.40e-04 | 243 | 148 | 8 | int:RHOV | |
| Interaction | ORC6 interactions | 4.58e-04 | 49 | 148 | 4 | int:ORC6 | |
| Interaction | RND1 interactions | 4.78e-04 | 246 | 148 | 8 | int:RND1 | |
| Interaction | HDAC1 interactions | CCNL2 ARID4B NUP107 RPAP3 RUFY1 CREB1 SPAG5 IQGAP1 FANCD2 AKAP9 DZIP3 EHMT1 PLEKHA5 CCAR2 TASOR EP300 GOLGA4 GOLGB1 TANGO6 | 4.95e-04 | 1108 | 148 | 19 | int:HDAC1 |
| Interaction | CTTN interactions | ATP6V1C1 NAA15 TTC21A SPTBN1 IDE IQGAP1 AKAP9 NDC80 PIP4K2A CADPS2 EP300 | 5.02e-04 | 450 | 148 | 11 | int:CTTN |
| Interaction | TNIK interactions | SPTBN1 TSC1 CEP63 AKAP9 MAGED2 EHMT1 PLEKHA5 CCAR2 UNC13A GOLGA4 | 5.24e-04 | 381 | 148 | 10 | int:TNIK |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.71e-05 | 17 | 90 | 3 | 486 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.28e-04 | 20 | 90 | 3 | 548 | |
| GeneFamily | UNC13 homologs | 1.46e-04 | 4 | 90 | 2 | 836 | |
| GeneFamily | V-type ATPases | 1.97e-04 | 23 | 90 | 3 | 415 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.73e-04 | 115 | 90 | 5 | 769 | |
| GeneFamily | Cyclins|F-boxes other | 9.58e-04 | 39 | 90 | 3 | 560 | |
| GeneFamily | C2 domain containing protein kinases | 1.07e-03 | 10 | 90 | 2 | 835 | |
| GeneFamily | Cadherin related | 3.17e-03 | 17 | 90 | 2 | 24 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 NAA15 ARID4B RPAP3 ORC3 CREB1 CEP63 SLC30A5 NDC80 CAPRIN2 GKAP1 ASPM EEA1 SEC63 TASOR DEK GOLGA4 GOLGB1 KIF11 | 5.99e-09 | 656 | 148 | 19 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 CREB1 EFR3A FAT1 ATP6V1H AKAP9 PSME4 NDC80 MTIF2 PIP4K2A NCOA1 UTP20 PKN2 DENND5A MAP2K1 TASOR DEK ACBD3 HERC4 GOLGA4 KIF11 | 1.62e-08 | 856 | 148 | 21 | M4500 |
| Coexpression | GSE7852_LN_VS_FAT_TREG_UP | RASSF2 JAGN1 BAG4 KAT2A UBLCP1 ZNF518A SLC38A1 PIP4K2A IFIT1B | 2.15e-06 | 200 | 148 | 9 | M5739 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | CCNL2 USP34 SPTBN1 PON3 NCF2 IDE PDPK2P UBLCP1 SPAG5 JAK1 PSME4 PLCB1 ACBD3 GOLGA4 KIF11 PMFBP1 | 4.84e-06 | 741 | 148 | 16 | MM1037 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | NAA15 ARID4B VEZT RPAP3 BAG4 COPS2 PREPL ZNF518A EFR3A SLC38A1 EEA1 SEC63 TASOR DEK GOLGA4 | 8.54e-06 | 687 | 148 | 15 | M41022 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | CCNL2 USP34 FOS SPTBN1 BAG4 PON3 NCF2 IDE PDPK2P SPAG5 JAK1 PSME4 PIP4K2A ACBD3 KIF11 | 8.84e-06 | 689 | 148 | 15 | MM1041 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | CCNL2 USP34 SPTBN1 PON3 NCF2 IDE UBLCP1 SPAG5 JAK1 PSME4 PLCB1 ACBD3 GOLGA4 KIF11 PMFBP1 | 8.99e-06 | 690 | 148 | 15 | M12224 |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | CCNL2 USP34 FOS SPTBN1 BAG4 PON3 NCF2 IDE PDPK2P SPAG5 JAK1 PSME4 PIP4K2A ACBD3 KIF11 | 9.63e-06 | 694 | 148 | 15 | MM1039 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | CCNL2 USP34 FOS SPTBN1 BAG4 PON3 NCF2 IDE SPAG5 JAK1 PSME4 PIP4K2A ACBD3 KIF11 | 1.26e-05 | 623 | 148 | 14 | M15896 |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | CCNL2 USP34 FOS SPTBN1 BAG4 PON3 NCF2 IDE SPAG5 JAK1 PSME4 PIP4K2A ACBD3 KIF11 | 1.28e-05 | 624 | 148 | 14 | M4371 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CREB1 FAT1 AKAP9 NDC80 PIP4K2A NCOA1 PKN2 DENND5A MAP2K1 TASOR GOLGA4 KIF11 | 1.43e-05 | 466 | 148 | 12 | M13522 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | USP34 NAA15 NUP107 RPAP3 RALGPS2 MFN1 IQGAP1 CEP63 SLC38A1 NDC80 ANAPC1 ASPM PLCB1 HERC4 KIF11 | 1.51e-05 | 721 | 148 | 15 | M10237 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | KNTC1 ATP6V1C1 NAA15 RPAP3 RALGPS2 ABCF2 IDE MFN1 FANCD2 SLC30A5 FANCI MTIF2 BTG3 HERC4 | 1.82e-05 | 644 | 148 | 14 | M10501 |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP | 1.89e-05 | 200 | 148 | 8 | M9584 | |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 1.89e-05 | 200 | 148 | 8 | M3020 | |
| Coexpression | FISCHER_DREAM_TARGETS | KNTC1 NAA15 NUP107 ORC3 SPAG5 ZNF518A FANCD2 SLC38A1 FANCB NDC80 ANAPC1 FANCI ASPM DZIP3 EMG1 DEK KIF11 | 3.53e-05 | 969 | 148 | 17 | M149 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | NAA15 NUP107 BAG4 ITGAE COPS2 SPAG5 FANCD2 HOOK3 SLC30A5 FBXO8 NDC80 FANCI ASPM BTG3 DEK KIF11 | 3.83e-05 | 877 | 148 | 16 | M2241 |
| Coexpression | ELVIDGE_HIF1A_TARGETS_UP | 3.91e-05 | 67 | 148 | 5 | M17905 | |
| Coexpression | WANG_LMO4_TARGETS_DN | ATP6V1C1 SPTBN1 ABCF2 IQGAP1 CCDC83 ATP6V1H AKAP9 MTIF2 EHMT1 ACBD3 | 4.11e-05 | 361 | 148 | 10 | M12674 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 4.20e-05 | 290 | 148 | 9 | M45736 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN | 5.29e-05 | 170 | 148 | 7 | M6762 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MARK1 CCDC186 GDAP1 XPA PREPL EHD4 SLC38A1 STMN4 CD2 FAT2 GDAP1L1 AKAP9 CAPRIN2 KCNN3 EEA1 CSMD1 VPS53 UNC13A | 5.44e-05 | 1106 | 148 | 18 | M39071 |
| Coexpression | GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP | 5.70e-05 | 172 | 148 | 7 | M8932 | |
| Coexpression | ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP | 8.40e-05 | 41 | 148 | 4 | M7062 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 9.15e-05 | 250 | 148 | 8 | M11318 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | USP34 ARID4B RASSF2 RPS13 ITGAE CREB1 UBLCP1 IQGAP1 EFR3A SLC38A1 JAK1 CD2 AKAP9 PIP4K2A DZIP3 NCOA1 MAP2K1 TASOR DEK FMNL1 EP300 | 1.01e-04 | 1492 | 148 | 21 | M40023 |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 1.06e-04 | 190 | 148 | 7 | M761 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | KNTC1 NUP107 SPAG5 FANCD2 DOCK5 JAK1 NDC80 FANCI SNX25 CENPI ASPM KIF11 | 1.13e-04 | 578 | 148 | 12 | M2368 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | MARK1 GDAP1 TSC1 SLC38A1 STMN4 CD2 AKAP9 PLCB1 KCNN3 CSMD1 CADPS2 UNC13A | 1.25e-04 | 584 | 148 | 12 | M39068 |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN | 1.37e-04 | 198 | 148 | 7 | M8274 | |
| Coexpression | GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP | 1.42e-04 | 199 | 148 | 7 | M9502 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | 1.42e-04 | 199 | 148 | 7 | M3912 | |
| Coexpression | GSE7852_TREG_VS_TCONV_THYMUS_DN | 1.42e-04 | 199 | 148 | 7 | M5732 | |
| Coexpression | GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN | 1.42e-04 | 199 | 148 | 7 | M5632 | |
| Coexpression | GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP | 1.46e-04 | 200 | 148 | 7 | M9474 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP | 1.46e-04 | 200 | 148 | 7 | M4622 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 1.46e-04 | 200 | 148 | 7 | M8081 | |
| Coexpression | GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP | 1.46e-04 | 200 | 148 | 7 | M3271 | |
| Coexpression | GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP | 1.46e-04 | 200 | 148 | 7 | M5831 | |
| Coexpression | GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN | 1.46e-04 | 200 | 148 | 7 | M7276 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP | 1.46e-04 | 200 | 148 | 7 | M3774 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 1.46e-04 | 200 | 148 | 7 | M7168 | |
| Coexpression | GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN | 1.46e-04 | 200 | 148 | 7 | M7347 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | 1.46e-04 | 200 | 148 | 7 | M5069 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN | 1.46e-04 | 200 | 148 | 7 | M7796 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN | 1.46e-04 | 200 | 148 | 7 | M9277 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_UP | 1.46e-04 | 200 | 148 | 7 | M5675 | |
| Coexpression | GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP | 1.46e-04 | 200 | 148 | 7 | M6950 | |
| Coexpression | ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER | 1.48e-04 | 140 | 148 | 6 | M15664 | |
| Coexpression | WELCSH_BRCA1_TARGETS_UP | 1.51e-04 | 201 | 148 | 7 | M5490 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | KNTC1 NUP107 SPAG5 FANCD2 DOCK5 JAK1 NDC80 FANCI SNX25 CENPI ASPM KIF11 | 1.53e-04 | 597 | 148 | 12 | MM1309 |
| Coexpression | CHIARETTI_T_ALL_RELAPSE_PROGNOSIS | 1.60e-04 | 19 | 148 | 3 | M17204 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 1.70e-04 | 429 | 148 | 10 | M29 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 1.80e-04 | 432 | 148 | 10 | MM419 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | KNTC1 ABCF2 SPAG5 ATP6V1H NDC80 FANCI CENPI ASPM EMG1 UTP20 DDX41 KIF11 | 1.93e-04 | 612 | 148 | 12 | M4772 |
| Coexpression | TBK1.DF_DN | 2.30e-04 | 286 | 148 | 8 | M2864 | |
| Coexpression | WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 | 2.31e-04 | 53 | 148 | 4 | M10169 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | ATP6V1C1 ARID4B FOS NCF2 TSC1 CHKA COPS2 AKAP9 NCOA1 ACBD3 HERC4 EP300 GOLGB1 ATP6V0A2 | 2.42e-04 | 822 | 148 | 14 | M6782 |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 2.56e-04 | 155 | 148 | 6 | M39041 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | KNTC1 SPAG5 SLC38A1 SLC9A2 NDC80 FANCI MTIF2 CENPI ASPM KIF11 | 2.87e-04 | 458 | 148 | 10 | M8520 |
| Coexpression | WINNEPENNINCKX_MELANOMA_METASTASIS_UP | 3.25e-04 | 162 | 148 | 6 | M6387 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | KNTC1 NAA15 NUP107 VEZT MARK1 ORC3 ABCF2 COPS2 SPAG5 NDC80 ANAPC1 ANO6 FANCI CENPI ASPM BTG3 DEK VPS53 KIF11 | 3.74e-04 | 1407 | 148 | 19 | M14427 |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 4.00e-04 | 236 | 148 | 7 | M130 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | KNTC1 NCF2 SPAG5 FANCD2 NDC80 FANCI ASPM PLCB1 PLEKHA5 KIF11 | 4.02e-04 | 478 | 148 | 10 | M45785 |
| Coexpression | ZHONG_PFC_C1_OPC | 4.21e-04 | 238 | 148 | 7 | M39096 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 4.83e-04 | 402 | 148 | 9 | MM454 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_DN | 4.86e-04 | 320 | 148 | 8 | M10279 | |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 5.05e-04 | 176 | 148 | 6 | M9137 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 5.17e-04 | 323 | 148 | 8 | M2156 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | USP34 RPAP3 FOS SPTBN1 IQGAP1 HOOK3 ANO6 FANCI CENPI ASPM EEA1 SEC63 CADPS2 DEK | 5.48e-04 | 892 | 148 | 14 | M18120 |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 5.52e-04 | 179 | 148 | 6 | M39308 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP | 5.52e-04 | 179 | 148 | 6 | M3268 | |
| Coexpression | MURARO_PANCREAS_DELTA_CELL | 5.64e-04 | 250 | 148 | 7 | M39170 | |
| Coexpression | SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN | 6.53e-04 | 7 | 148 | 2 | M19757 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | 7.11e-04 | 260 | 148 | 7 | M1471 | |
| Coexpression | ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR | 7.85e-04 | 127 | 148 | 5 | M2608 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_2 | 8.50e-04 | 33 | 148 | 3 | M17333 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 8.86e-04 | 196 | 148 | 6 | M9243 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 9.10e-04 | 197 | 148 | 6 | M8271 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 9.10e-04 | 197 | 148 | 6 | M9862 | |
| Coexpression | GARY_CD5_TARGETS_DN | 9.17e-04 | 440 | 148 | 9 | M13893 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON | 9.33e-04 | 132 | 148 | 5 | M3434 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP | 9.34e-04 | 198 | 148 | 6 | M7459 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 9.58e-04 | 199 | 148 | 6 | M9498 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP | 9.58e-04 | 199 | 148 | 6 | M4607 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN | 9.58e-04 | 199 | 148 | 6 | M9422 | |
| Coexpression | GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN | 9.58e-04 | 199 | 148 | 6 | M4673 | |
| Coexpression | GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP | 9.58e-04 | 199 | 148 | 6 | M8324 | |
| Coexpression | GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP | 9.58e-04 | 199 | 148 | 6 | M8418 | |
| Coexpression | GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP | 9.58e-04 | 199 | 148 | 6 | M8435 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP | 9.58e-04 | 199 | 148 | 6 | M8961 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 9.58e-04 | 199 | 148 | 6 | M5893 | |
| Coexpression | GSE3982_CTRL_VS_LPS_4H_MAC_DN | 9.58e-04 | 199 | 148 | 6 | M5368 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN | 9.58e-04 | 199 | 148 | 6 | M6632 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 9.58e-04 | 199 | 148 | 6 | M3070 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | USP34 ATP6V1C1 MARK1 ORC3 GDAP1 COPS2 PREPL EFR3A TTC7B PLCB1 BTG3 SEC63 GOLGA4 GOLGB1 | 9.67e-04 | 946 | 148 | 14 | M39169 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN | 9.83e-04 | 200 | 148 | 6 | M8110 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN | 9.83e-04 | 200 | 148 | 6 | M9352 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 9.83e-04 | 200 | 148 | 6 | M9313 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN | 9.83e-04 | 200 | 148 | 6 | M7059 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | KNTC1 ATP6V1C1 CDS1 NAA15 NUP107 RPAP3 ABCF2 IDE FBXO47 UBLCP1 ZNF518A FANCD2 FANCB FANCI CENPI CAPRIN2 GKAP1 DZIP3 UTP20 KIF11 | 8.32e-07 | 822 | 145 | 20 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | UNC13B KNTC1 CDS1 NUP107 IDE FBXO47 UBLCP1 ZNF518A CHUK FANCD2 FANCB ATP6V1H VPS33B FANCI SNX25 CENPI CAPRIN2 GKAP1 DZIP3 | 3.28e-06 | 820 | 145 | 19 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | KNTC1 RPAP3 RALGPS2 UBLCP1 SPAG5 FANCD2 NDC80 FANCI SNX25 CENPI ASPM KIF11 | 1.21e-05 | 380 | 145 | 12 | GSM538207_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | KNTC1 CDS1 FBXO47 ZNF518A CHUK FANCD2 FANCB FANCI CENPI CAPRIN2 GKAP1 DZIP3 | 1.38e-05 | 385 | 145 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | KNTC1 SPAG5 FANCD2 DOCK5 FANCB CD2 NDC80 FANCI CENPI ASPM DEK KIF11 | 2.56e-05 | 410 | 145 | 12 | GSM538387_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | UNC13B NAA15 ARID4B RPAP3 GDAP1 SPAG5 ZNF518A CEP63 SLC38A1 STMN4 AKAP9 MTIF2 PIP4K2A GKAP1 ASPM KCNN3 UTP20 DEK GOLGA4 | 4.50e-05 | 989 | 145 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.35e-05 | 192 | 145 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.14e-05 | 266 | 145 | 9 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.28e-05 | 330 | 145 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 1.33e-04 | 114 | 145 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | RPAP3 GDAP1 SPAG5 CEP63 STMN4 AKAP9 MTIF2 GKAP1 ASPM KCNN3 DEK GOLGA4 | 1.63e-04 | 498 | 145 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.90e-04 | 173 | 145 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | KNTC1 NUP107 UBLCP1 FANCD2 FANCB ATP6V1H VPS33B FANCI CENPI GKAP1 | 1.93e-04 | 361 | 145 | 10 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.30e-04 | 369 | 145 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.94e-04 | 311 | 145 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | CCDC186 RALGPS2 TSC1 XPA UBLCP1 PREPL MFN1 JAK1 AKAP9 PLEKHA5 EEA1 SEC63 ACBD3 VPS53 RBM18 | 2.96e-04 | 780 | 145 | 15 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3 | KNTC1 RALGPS2 SPAG5 CD2 SLC30A5 PSME4 NDC80 CENPI ASPM KIF11 | 3.09e-04 | 383 | 145 | 10 | GSM399448_500 |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | KNTC1 RALGPS2 SPAG5 FANCD2 SLC30A5 PSME4 NDC80 CENPI ASPM KIF11 | 3.94e-04 | 395 | 145 | 10 | GSM538340_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | PREPL EFR3A JAK1 HOOK3 TTC7B ANAPC1 ASPM DZIP3 PLEKHA5 KIF11 | 4.10e-04 | 397 | 145 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | RPAP3 JAGN1 BAG4 XPA IDE KAT2A COPS2 UBLCP1 ZNF518A SLC38A1 DOCK5 AKAP9 NDC80 VPS33B CENPI CAPRIN2 UTP20 CADPS2 DEK RBM18 KIF11 | 4.16e-04 | 1371 | 145 | 21 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.38e-04 | 261 | 145 | 8 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | KNTC1 ATP6V1C1 NUP107 RPAP3 TSC1 IDE FBXO47 UBLCP1 ZNF518A FANCD2 FANCB PIP4K2A CAPRIN2 DZIP3 UTP20 | 4.40e-04 | 810 | 145 | 15 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 4.52e-04 | 402 | 145 | 10 | GSM605898_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | KNTC1 ATP6V1C1 NUP107 RPAP3 UBLCP1 ZNF518A FANCD2 FANCB UTP20 | 4.83e-04 | 333 | 145 | 9 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | KNTC1 CDS1 IDE FBXO47 UBLCP1 FANCD2 FANCB FANCI CENPI CAPRIN2 | 4.88e-04 | 406 | 145 | 10 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ARID4B RPAP3 ORC3 RALGPS2 SPAG5 TTC7B MTIF2 DZIP3 TASOR DEK ACBD3 GOLGB1 | 5.04e-04 | 564 | 145 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | KNTC1 RALGPS2 SPAG5 FANCD2 FANCB NDC80 FANCI CENPI ASPM KIF11 | 5.17e-04 | 409 | 145 | 10 | GSM399452_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RPAP3 PREPL MFN1 SPAG5 ZNF518A CEP63 AKAP9 MTIF2 GKAP1 ASPM KCNN3 EEA1 DEK VPS53 GOLGA4 | 5.74e-04 | 831 | 145 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 6.00e-04 | 417 | 145 | 10 | GSM399403_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 6.23e-04 | 419 | 145 | 10 | GSM476664_500 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | SPAG5 FANCB NDC80 FANCI GALNT8 CENPI ASPM FBXO43 KIF11 PMFBP1 | 2.79e-10 | 169 | 148 | 10 | eb0c993ef2eea73bc4881182520922ce9ae9368f |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | USP34 CCDC186 SPTBN1 ZNF518A IQGAP1 PSME4 MTIF2 PKN2 TASOR GOLGB1 | 9.20e-10 | 191 | 148 | 10 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | USP34 CCDC186 SPTBN1 ZNF518A IQGAP1 PSME4 MTIF2 PKN2 TASOR GOLGA4 | 9.20e-10 | 191 | 148 | 10 | 09db184cb90fe282a14474d7217068c58092c6f8 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | USP34 CCDC186 SPTBN1 ZNF518A IQGAP1 PSME4 MTIF2 PKN2 TASOR GOLGB1 | 9.20e-10 | 191 | 148 | 10 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.02e-09 | 193 | 148 | 10 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | KNTC1 SPAG5 FANCD2 FANCB NDC80 FANCI CENPI ASPM FBXO43 KIF11 | 1.07e-09 | 194 | 148 | 10 | f9070035553bc68106a9e0bdf4b507715a138aba |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | KNTC1 SPAG5 FANCD2 FANCB NDC80 FANCI CENPI ASPM FBXO43 KIF11 | 1.24e-09 | 197 | 148 | 10 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-09 | 174 | 148 | 9 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.76e-09 | 180 | 148 | 9 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.13e-08 | 183 | 148 | 9 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.24e-08 | 185 | 148 | 9 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-08 | 187 | 148 | 9 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.56e-08 | 190 | 148 | 9 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.96e-08 | 195 | 148 | 9 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.04e-08 | 196 | 148 | 9 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.04e-08 | 196 | 148 | 9 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.04e-08 | 196 | 148 | 9 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.14e-08 | 197 | 148 | 9 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 2.23e-08 | 198 | 148 | 9 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-08 | 198 | 148 | 9 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.33e-08 | 199 | 148 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG|World / Primary Cells by Cluster | 2.43e-08 | 200 | 148 | 9 | 7596143925cd403ec7baceef87d19d570e48586a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-08 | 200 | 148 | 9 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-07 | 169 | 148 | 8 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-07 | 171 | 148 | 8 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-07 | 175 | 148 | 8 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-07 | 181 | 148 | 8 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-07 | 182 | 148 | 8 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.86e-07 | 183 | 148 | 8 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 187 | 148 | 8 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-07 | 189 | 148 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.48e-07 | 190 | 148 | 8 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.58e-07 | 191 | 148 | 8 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-07 | 191 | 148 | 8 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.02e-07 | 195 | 148 | 8 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.14e-07 | 196 | 148 | 8 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.14e-07 | 196 | 148 | 8 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.14e-07 | 196 | 148 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.40e-07 | 198 | 148 | 8 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-11|World / Primary Cells by Cluster | 3.40e-07 | 198 | 148 | 8 | 672c6faeed54e1397e12c0aac1a5cbd19c684f06 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.53e-07 | 199 | 148 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 3.53e-07 | 199 | 148 | 8 | 2e222e2e080bc2be63d0fdf285e1790676b911ef | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 3.53e-07 | 199 | 148 | 8 | 4142d5b1b20212508f95841fdac4efb7655616cb | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-07 | 199 | 148 | 8 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 3.53e-07 | 199 | 148 | 8 | a0c20b97cb38e493b47a06e9501fc165a78c61b2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.53e-07 | 199 | 148 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.53e-07 | 199 | 148 | 8 | 2fbf94f7858250088e0f5ce1ff51892730a13ae8 | |
| ToppCell | Non-neuronal-Dividing|World / Primary Cells by Cluster | 3.67e-07 | 200 | 148 | 8 | 50fa7b34a05f2c5ebbc7d113bd8e31326688a231 | |
| ToppCell | distal-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.67e-07 | 200 | 148 | 8 | 0cd3b01fb7f579e5abf000adb8ec8adc7cd779c4 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.67e-07 | 200 | 148 | 8 | 87e293c0882e2754756a2210a6c04723dc89f81b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.67e-07 | 200 | 148 | 8 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Proliferating|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-07 | 200 | 148 | 8 | 9279415f5e76cb5b4e071c6582ac249b72dd694c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-07 | 200 | 148 | 8 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.67e-07 | 200 | 148 | 8 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Proliferating-Cycling|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-07 | 200 | 148 | 8 | d582385b2dbb25eeba1b22c5d258a8f26a40ef8b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.67e-07 | 200 | 148 | 8 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-07 | 200 | 148 | 8 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-07 | 200 | 148 | 8 | 008f137920cc3b599376706803c111d1d0ec17ef | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 3.67e-07 | 200 | 148 | 8 | a1ef1b4824b2d56f6b2af15d698f58fc5590c392 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-07 | 200 | 148 | 8 | 63f9481059be608ddc9fe9c7a8f8503fce9755dd | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.67e-07 | 200 | 148 | 8 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-17|World / Primary Cells by Cluster | 3.67e-07 | 200 | 148 | 8 | 4417f14d45ce683c1a45ec989ae63ee6c047353e | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia|World / Primary Cells by Cluster | 3.67e-07 | 200 | 148 | 8 | ecbbad00e16041a9e1cd88d8bd7279a1b52c0aa4 | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.67e-07 | 200 | 148 | 8 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-07 | 200 | 148 | 8 | 2154c976f96489d0fa7bfe6ac1cd21edcbefe735 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells-Neuroepithelial_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-07 | 200 | 148 | 8 | 0e119c2742f2be19fde8890d1227bf277ead976f | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.67e-07 | 200 | 148 | 8 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.67e-07 | 200 | 148 | 8 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 160 | 148 | 7 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-06 | 166 | 148 | 7 | 2642544070564debe2deb2938d2c33997bf5ef02 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-06 | 167 | 148 | 7 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-06 | 169 | 148 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-06 | 170 | 148 | 7 | 9e94fa0d05abed3438b28296a293767096d517d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-06 | 171 | 148 | 7 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-06 | 171 | 148 | 7 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-06 | 174 | 148 | 7 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-06 | 174 | 148 | 7 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-06 | 176 | 148 | 7 | 581045e61cdcdfa85701343d1a7c0a72a36606a7 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-06 | 177 | 148 | 7 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-06 | 177 | 148 | 7 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 178 | 148 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-06 | 178 | 148 | 7 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-06 | 180 | 148 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 180 | 148 | 7 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-06 | 181 | 148 | 7 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-06 | 181 | 148 | 7 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 181 | 148 | 7 | b203b616584cdbd0bbb0e382b2916d0bd49d3526 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-06 | 181 | 148 | 7 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-06 | 181 | 148 | 7 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 181 | 148 | 7 | c748c16fd20d1949d33ff6290dc9d9016c4dc86c | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.52e-06 | 181 | 148 | 7 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.61e-06 | 182 | 148 | 7 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-06 | 182 | 148 | 7 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-06 | 182 | 148 | 7 | 0fc45214f0b0766f69be6eff69cc4bec574023aa | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.81e-06 | 184 | 148 | 7 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.91e-06 | 185 | 148 | 7 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-06 | 185 | 148 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 186 | 148 | 7 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 186 | 148 | 7 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 186 | 148 | 7 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| Computational | Neighborhood of BUB1B | 4.71e-05 | 49 | 88 | 5 | GNF2_BUB1B | |
| Computational | Neighborhood of RFC4 | 1.26e-04 | 60 | 88 | 5 | GNF2_RFC4 | |
| Computational | Neighborhood of TTK | 2.77e-04 | 39 | 88 | 4 | GNF2_TTK | |
| Computational | Neighborhood of RFC3 | 3.37e-04 | 41 | 88 | 4 | GNF2_RFC3 | |
| Computational | Neighborhood of MLH1 | 3.70e-04 | 42 | 88 | 4 | GNF2_MLH1 | |
| Computational | Neighborhood of SMC4L1 | 6.09e-04 | 84 | 88 | 5 | GNF2_SMC4L1 | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | CHKA PSME4 NDC80 TGFBRAP1 CENPI ASPM NCOA1 PLEKHA5 EEA1 TASOR HERC4 KIF11 | 4.04e-09 | 190 | 147 | 12 | 2619_DN |
| Drug | resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.25e-07 | 176 | 147 | 10 | 958_DN | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | USP34 ATP6V1C1 VEZT RASSF2 BAG4 RALGPS2 CENPI EHMT1 PLCB1 VPS53 | 4.56e-07 | 190 | 147 | 10 | 5271_DN |
| Drug | wartmannin | FOS TRPC5 TSC1 RUFY1 CREB1 CHUK SLC38A1 JAK1 CD2 NDC80 EHMT1 PKN2 EEA1 MYO15A DDX41 MAP2K1 EP300 GOLGB1 PKN3 | 1.25e-06 | 811 | 147 | 19 | CID000005691 |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | KNTC1 ARID4B MFN1 NDC80 PIP4K2A CENPI PLEKHA5 KIF11 ATP6V0A2 | 3.05e-06 | 183 | 147 | 9 | 7498_DN |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 4.72e-06 | 193 | 147 | 9 | 3562_DN | |
| Drug | geldanamycin | CCDC186 SPTBN1 ZNF518A IQGAP1 CHUK SLC38A1 FANCB PSME4 ASPM EHMT1 EEA1 MAP2K1 | 5.47e-06 | 371 | 147 | 12 | ctd:C001277 |
| Drug | beryllium fluoride | 1.44e-05 | 8 | 147 | 3 | ctd:C035982 | |
| Drug | AC1OAGFW | 2.68e-05 | 184 | 147 | 8 | CID006857352 | |
| Drug | C768-0445; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.00e-05 | 187 | 147 | 8 | 973_DN | |
| Drug | resveratrol; Down 200; 50uM; MCF7; HG-U133A | 3.12e-05 | 188 | 147 | 8 | 595_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.24e-05 | 189 | 147 | 8 | 4304_DN | |
| Drug | Rolipram [61413-54-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.90e-05 | 194 | 147 | 8 | 5330_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A | 4.05e-05 | 195 | 147 | 8 | 6643_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 4.20e-05 | 196 | 147 | 8 | 4844_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; HL60; HT_HG-U133A | 4.67e-05 | 199 | 147 | 8 | 1862_UP | |
| Disease | Malignant neoplasm of breast | CDS1 UBD VPS39 FOS RUFY1 UBLCP1 CD2 SLC9A2 HOOK3 FBXO8 AKAP9 MAGED2 IL1RAPL2 EHMT1 PLCB1 NCOA1 UTP20 DEK EP300 GOLGB1 | 2.95e-07 | 1074 | 144 | 20 | C0006142 |
| Disease | Fanconi anemia | 3.98e-05 | 14 | 144 | 3 | cv:C0015625 | |
| Disease | Malignant Head and Neck Neoplasm | 6.35e-05 | 44 | 144 | 4 | C0278996 | |
| Disease | Bone marrow hypocellularity | 8.80e-05 | 18 | 144 | 3 | C1855710 | |
| Disease | Liver carcinoma | 2.02e-04 | 507 | 144 | 10 | C2239176 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.14e-04 | 24 | 144 | 3 | DOID:10595 (implicated_via_orthology) | |
| Disease | airway responsiveness measurement | 2.14e-04 | 24 | 144 | 3 | EFO_0006897 | |
| Disease | Fanconi Anemia | 2.42e-04 | 25 | 144 | 3 | C0015625 | |
| Disease | Pancytopenia | 2.73e-04 | 26 | 144 | 3 | C0030312 | |
| Disease | Acute monocytic leukemia | 2.73e-04 | 26 | 144 | 3 | C0023465 | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.28e-04 | 67 | 144 | 4 | C3463824 | |
| Disease | extraversion measurement | 3.50e-04 | 6 | 144 | 2 | EFO_0007913 | |
| Disease | Miller Dieker syndrome | 3.79e-04 | 29 | 144 | 3 | C0265219 | |
| Disease | Pick's disease (is_marker_for) | 4.89e-04 | 7 | 144 | 2 | DOID:11870 (is_marker_for) | |
| Disease | Abnormality of radial ray | 5.58e-04 | 33 | 144 | 3 | C4228778 | |
| Disease | dual specificity protein phosphatase 13 isoform A measurement | 6.50e-04 | 8 | 144 | 2 | EFO_0801549 | |
| Disease | Stuttering | 6.99e-04 | 143 | 144 | 5 | HP_0025268 | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 7.83e-04 | 37 | 144 | 3 | DOID:0050865 (is_marker_for) | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.04e-03 | 10 | 144 | 2 | GO_0097327, GO_0097328 | |
| Disease | Fanconi anemia (is_implicated_in) | 1.04e-03 | 10 | 144 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | Cutaneous Melanoma | 1.06e-03 | 41 | 144 | 3 | C0151779 | |
| Disease | cognitive impairment measurement | 1.30e-03 | 44 | 144 | 3 | EFO_0007998 | |
| Disease | Adenoid Cystic Carcinoma | 1.48e-03 | 100 | 144 | 4 | C0010606 | |
| Disease | Leukemia, Myelocytic, Acute | 1.63e-03 | 173 | 144 | 5 | C0023467 | |
| Disease | benign prostatic hyperplasia | 2.07e-03 | 14 | 144 | 2 | EFO_0000284 | |
| Disease | sulfate measurement | 2.07e-03 | 14 | 144 | 2 | EFO_0007864 | |
| Disease | health literacy measurement | 2.23e-03 | 53 | 144 | 3 | EFO_0010104 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 2.38e-03 | 15 | 144 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | birth weight, parental genotype effect measurement | 2.57e-03 | 192 | 144 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | Inherited oocyte maturation defect | 2.71e-03 | 16 | 144 | 2 | cv:CN238505 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELKNHVYKKTLQALI | 531 | Q9UPW8 | |
| KKIIHVLEKVQYLEQ | 381 | O95429 | |
| RLYLENKIHTLELKL | 826 | Q8N163 | |
| LQEKLQEIRKHYLSL | 1236 | Q4LE39 | |
| ERYHQLEIKKKLETL | 81 | Q5RHP9 | |
| HLLAEKIYKIQKELE | 631 | Q09472 | |
| GDILAYKEHLKSKLV | 596 | Q9UG63 | |
| ELKHEAEVTNYKIKL | 586 | Q99996 | |
| KYLQQEHIIKKLIKE | 201 | Q7Z3E2 | |
| IYKTLKTHLIEKGIL | 441 | Q92903 | |
| ELKLTGIYKKEEAHL | 3396 | Q96PZ7 | |
| NKKLKALYEQSLHIK | 211 | P61201 | |
| TLKIKHLKTDDQDIY | 91 | P06729 | |
| ENKISLLLKYFHKDV | 2281 | Q86UQ4 | |
| LEIHTIKNQILEKKY | 36 | Q96IX9 | |
| EKALLLSKLEYEEHK | 131 | Q5VSY0 | |
| IIKKILNLKSDEHIF | 361 | Q6ZPD9 | |
| HKLFEDYLIKVLEKI | 46 | Q8NCU1 | |
| LEKHEKDLYFLTNKI | 651 | Q14156 | |
| HKEYLAILKAVKIIQ | 2971 | Q8IZT6 | |
| EHYKITLEDTRKKII | 171 | Q8IWF9 | |
| YELAEVHKALLDKKN | 441 | Q7Z4T9 | |
| LSKEKREKLEAYQHL | 961 | P46940 | |
| IAVIKGLTYLREKHK | 171 | Q02750 | |
| NLDPKITEYHLLKLL | 31 | Q96H35 | |
| KYISKNELLLHLKTY | 16 | P50749 | |
| LKVKYLATLETLTKH | 266 | P23458 | |
| YTELSHIIKKQKEII | 661 | Q92830 | |
| HKLYLVFSKEELRKL | 886 | P57740 | |
| AKILEHDDVSYLKKI | 216 | Q96MZ0 | |
| DVLKIYKSELNKHIE | 436 | Q8IWA4 | |
| HLKSILSKDGVLYVK | 1686 | Q9H1A4 | |
| KIQREKYLTQKLLHE | 866 | Q4KMQ2 | |
| KYLTQKLLHENHLKD | 871 | Q4KMQ2 | |
| EVKDHYTLIVKALEK | 111 | Q14517 | |
| AIEQYEKFLIHLSKK | 1256 | Q9NVI1 | |
| CILKKYRLVLHTSKE | 201 | Q6TGC4 | |
| LKEIDKNDHLYILLS | 336 | Q9UNF1 | |
| KYDLAIKDLKEALIQ | 86 | P19878 | |
| VKIKLHKIIYRLVED | 591 | P46199 | |
| VTLKYEIKKLIYVHL | 31 | Q8N5M9 | |
| LLKEKEKLEFILAAH | 186 | P01100 | |
| ELKKLYAQLEVHKTK | 681 | Q6PRD1 | |
| VSKLFLKEHLYQLLE | 1881 | Q9UKN7 | |
| LEEKNKKYSLIVAQH | 1801 | Q13439 | |
| YHKKEELLRLLQLKQ | 146 | Q8NDA2 | |
| LYQHRELDLKIAIKS | 31 | O15111 | |
| KHLQETKLQLVKEEY | 466 | P52732 | |
| KRDYIHSLKLLNVLE | 96 | Q8IZU0 | |
| FLKDEKYHSLPIIIK | 1116 | P38570 | |
| KKLDHEKISSYQLKI | 1716 | Q9NYQ8 | |
| LIYKHTKLLKKIDHA | 581 | Q9UGI6 | |
| DKLKLYASHSQFIKL | 316 | Q9BW91 | |
| RLKSKLLDHDNVKYL | 191 | Q8TB36 | |
| LLDHDNVKYLKKILD | 196 | Q8TB36 | |
| ELFKEVVVHLLKLYK | 561 | Q5GLZ8 | |
| IDIYHLLKARKSKEQ | 51 | Q9NRD0 | |
| QEYELIIKKKHRDLD | 246 | Q9C075 | |
| YEQLLDIKLHLEKEI | 366 | Q7Z3Z0 | |
| VYKVKSNHILEKLAL | 426 | P50748 | |
| YEEKLKLVALHKQVL | 106 | Q9H3P7 | |
| LAKHLIKIKLDGYEL | 506 | Q9H223 | |
| YAIKILEKRHIIKEN | 81 | Q6A1A2 | |
| KKADVDAIHEYLLLK | 441 | Q9UJV9 | |
| LKKILKGILDYNHEI | 76 | Q86VS8 | |
| LKKELLIHKNVLESY | 421 | Q86Y13 | |
| TLIELFLVKAKIYKH | 406 | Q9BXJ9 | |
| HLLLKEKIISKSYKA | 411 | Q8NB91 | |
| LSLLSLYGIHKQKEK | 241 | P15309 | |
| DILTELKYRNLKHIL | 496 | Q4G163 | |
| LLKKEQDYTKLEEKH | 311 | Q15075 | |
| YAHESKLKSFLLVKL | 256 | Q8NA47 | |
| EQYKVLLEKLLLEHC | 1166 | Q9H7D0 | |
| YKQELKKLHEELCIL | 96 | Q96MT8 | |
| KKLHEELCILKRSYE | 101 | Q96MT8 | |
| LQLYARKKVDLTHLE | 281 | Q96S94 | |
| TEESRIKKLHKLLSY | 266 | P35790 | |
| IKKLHKLLSYNLPLE | 271 | P35790 | |
| GELKVHLDEKIKLYN | 226 | Q9NY28 | |
| KKTDELRNLHKLLYN | 101 | P35659 | |
| LSKYDTLKIIKHLQE | 536 | Q5T1B0 | |
| DKAITHYLKGLKIEK | 396 | Q5T764 | |
| SPYHLQDKKLVLEKL | 406 | Q5T1N1 | |
| LHIYQLKTLIKIVKK | 1226 | Q86UW7 | |
| LKKLKDEYVLRLQHC | 236 | A2IDD5 | |
| LKQLLSDHELTKKLY | 901 | Q6IQ26 | |
| KFYQKLLELEKHIRV | 311 | P56937 | |
| TTYKHLKDLLSKLLN | 296 | Q6IMN6 | |
| LIEELKALKDLYCHK | 311 | P16220 | |
| KYIVHRDLKAENLLL | 176 | Q9P0L2 | |
| KQTLLHYLVKVIAEK | 876 | O95466 | |
| KERLKYIHKILTEVS | 131 | Q5MNV8 | |
| EHLKQLYKIVPIKDI | 296 | P14735 | |
| VCHLLYLLTKKENVK | 201 | Q92674 | |
| TEYKHVDLVKLLLSK | 881 | Q9H9B1 | |
| AIIDILTHYDAKKKA | 356 | P48426 | |
| LKHIVELQIILEKYL | 816 | Q9BXW9 | |
| HEKKIIYRDLKLDNL | 676 | Q6P5Z2 | |
| KTAKKLYELNNLHAL | 126 | Q86X27 | |
| LQKTDLYHLQKSLLE | 521 | Q9UBD5 | |
| LDKALQKEKHYLQTT | 711 | Q8TBY8 | |
| KAEQLTKHLFLLLKD | 2151 | O75691 | |
| KTLKKLREVLHELYK | 326 | P21283 | |
| ILYKRLSVLVKGHDK | 71 | P82664 | |
| KNYELLKILTKLLEV | 386 | Q9UI12 | |
| KELEKLDDIVQHIYK | 1156 | Q96R06 | |
| LYEKLLIKEEEKHAS | 396 | Q9H3E2 | |
| HASVLLRKKDLIYKI | 341 | Q9NP60 | |
| KESKDHQLLRYLLDK | 741 | Q15788 | |
| ADYLKVLIDNKHLLS | 221 | Q96T51 | |
| HLYNQKLREKLKEEE | 111 | Q9H479 | |
| KHLAIEKKKTETLLY | 351 | O75343 | |
| KKISILKDHGYIENL | 316 | Q9NVD3 | |
| KYQEAELLKHLAEKR | 106 | Q9H169 | |
| EYKHIKAKLRLLEVL | 561 | Q8NE31 | |
| HKIVYRDLKLDNLLL | 776 | Q16513 | |
| EKKLKDLDYTRTVLH | 196 | Q8TEV9 | |
| KHYASEEIKEKLLQL | 1981 | Q01082 | |
| LSLLTLLNVYQKKHL | 1386 | Q9UK61 | |
| AEKLTLILQEKYKNH | 31 | Q14201 | |
| YGIDKEKTIHLTLKV | 66 | O15205 | |
| VKYLEHLVIDKRLQK | 591 | Q8WUH2 | |
| LAKKDHLLLEQKKYL | 916 | Q92574 | |
| HLLLEQKKYLEDVKL | 921 | Q92574 | |
| SIVSLYKKLEIKHAI | 551 | Q9UBY0 | |
| KILHDFYIEKEKPLL | 596 | Q9H6T3 | |
| EDLYHLIKKAVAVRK | 86 | P62277 | |
| EVLSAVLKDLYHLLK | 1036 | Q9C0B7 | |
| HKKYKIKTIQDLVSL | 401 | Q9UGP8 | |
| HKKITAQIKFLYEEL | 696 | Q4J6C6 | |
| SLVYLKTIKHELLKS | 151 | Q15166 | |
| LKDEELKSHVYKKTL | 451 | O14795 | |
| IHYALKNVKIDLPKI | 41 | Q6AHZ1 | |
| LLLAKVYKSHKKEAV | 841 | Q8NDW8 | |
| SKEDHVLFIKLLYEL | 91 | Q14997 | |
| IIKKFIKQHLSEYLV | 256 | Q5VIR6 | |
| SEKYQKREHIKLLIQ | 1026 | Q9NQ66 | |
| YELLNCDKHKSILLK | 61 | Q92979 | |
| HKLITKTEAKQEYLL | 136 | P23025 | |
| LLLGESKLEQYLKEH | 46 | Q86TV6 | |
| YEKELHIALEKIQKI | 656 | Q8TAD4 | |
| DKELLKLTQYLKEIA | 281 | Q8WVY7 | |
| DLAKLKVAIKYHQKE | 286 | Q9UL62 | |
| KELLKIKSAHKLLYA | 1426 | Q70CQ2 | |
| AKLQVTLKKYSVHLE | 191 | Q9HBM0 | |
| ALEEKLQQLHKEKYT | 651 | Q9HAU0 | |
| LLHKYQSKDDILILT | 341 | Q9H2H9 | |
| SILKQHEVDKLYKVE | 56 | Q9H267 | |
| EKLRKNLLELIEYTH | 116 | Q9Y487 | |
| IILYEKKGLHEKALQ | 506 | Q96JC1 | |
| STVHLIQLLENYKKK | 101 | Q309B1 | |
| EKHKELQKEYEILLQ | 1606 | Q14789 | |
| QLAEYHKLARKLKLI | 411 | O14777 |